Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Wiener Boerse  >  Marinomed Biotech AG    MARI   ATMARINOMED6

MARINOMED BIOTECH AG

(MARI)
  Report
End-of-day quote. End-of-day quote Wiener Boerse - 11/26
118 EUR   -0.84%
 SummaryChartsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Wiener Boerse
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
119 117 119 118 119 Last
1973 1023 583 406 652 Volume
-0.83% -1.68% +1.71% -0.84% +0.85% Change
Financials
Sales 2020 7,44 M 8,90 M 8,90 M
Net income 2020 -6,23 M -7,45 M -7,45 M
Net Debt 2020 1,15 M 1,38 M 1,38 M
P/E ratio 2020 -28,2x
Yield 2020 -
Sales 2021 15,0 M 17,9 M 17,9 M
Net income 2021 -3,44 M -4,11 M -4,11 M
Net Debt 2021 8,50 M 10,2 M 10,2 M
P/E ratio 2021 -51,2x
Yield 2021 -
Capitalization 175 M 210 M 210 M
EV / Sales 2020 23,7x
EV / Sales 2021 12,3x
Nbr of Employees 35
Free-Float 58,4%
More Financials
Company
Marinomed Biotechnologie GmbH is an Austria-based biopharmaceutical company engaged in the pharmaceuticals industry. The Company develops anti-viral and immunological therapies, such as nasal sprays, using the antiviral respiratory technology platform MAVIREX, which target more than 200 different respiratory virus strains based on Carragelose, a red algae derived polymer. The company also offers products for the... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about MARINOMED BIOTECH AG

- No features available -

More news
News in other languages on MARINOMED BIOTECH AG
04/16MARINOMED BIOTECH : Wiener Biotech-Firma Marinomed profitiert von Corona-Krise
01/27EANS ADHOC : Marinomed Biotech AG
01/22EANS ADHOC : Marinomed Biotech AG
2019EANS ADHOC : Marinomed Biotech AG
2019EANS ADHOC : Marinomed Biotech AG
More news
Chart MARINOMED BIOTECH AG
Duration : Period :
Marinomed Biotech AG Technical Analysis Chart | MARI | ATMARINOMED6 | MarketScreener
Technical analysis trends MARINOMED BIOTECH AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 132,90 €
Last Close Price 119,00 €
Spread / Highest target 14,0%
Spread / Average Target 11,7%
Spread / Lowest Target 8,40%
EPS Revisions
Sector and Competitors
1st jan.Capitalization (M$)
MARINOMED BIOTECH AG18.00%210
DAIICHI SANKYO COMPANY, LIMITED56.60%72 682
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 850
YUNNAN BAIYAO GROUP CO.,LTD7.23%18 673
ORION OYJ-3.10%6 712
SWEDISH ORPHAN BIOVITRUM AB1.42%5 440